(19)
(11) EP 3 621 643 A1

(12)

(43) Date of publication:
18.03.2020 Bulletin 2020/12

(21) Application number: 18798204.6

(22) Date of filing: 11.05.2018
(51) International Patent Classification (IPC): 
A61K 39/015(2006.01)
C12N 15/09(2006.01)
 C07K 14/445(2006.01)
C12N 1/21(2006.01)
(86) International application number:
PCT/US2018/032366
(87) International publication number:
WO 2018/209265 (15.11.2018 Gazette 2018/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 11.05.2017 US 201762504863 P
20.09.2017 US 201762560971 P
27.09.2017 US 201762564066 P

(71) Applicants:
  • Atreca, Inc.
    Redwood City, California 94063 (US)
  • Kymab Limited
    Cambridge, Cambridgeshire CB33 3AT (GB)

(72) Inventors:
  • LIANG, Qi
    Cambridge Cambridgeshire CD33 SAT (GB)
  • CARROLL, Sean Matthew
    Redwood City, California 94063 (US)
  • EMERLING, Daniel Eric
    Redwood City, California 94063 (US)
  • BRADLEY, Allan
    Cambridge Cambridgeshire CD33 SAT (GB)
  • KELLAM, Paul
    Cambridge Cambridgeshire CD33 SAT (GB)
  • BINTER, pela
    Cambridge Cambridgeshire CD33 SAT (GB)
  • WATSON, Simon James
    Cambridge Cambridgeshire CD33 SAT (GB)

(74) Representative: CMS Cameron McKenna Nabarro Olswang LLP 
Cannon Place 78 Cannon Street
London EC4N 6AF
London EC4N 6AF (GB)

   


(54) ANTI-MALARIAL ANTIBODIES THAT BIND CIRCUMSPOROZOITE PROTEIN